Clinical Trial Update: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of XmAb541 in advanced solid tumors is currently recruiting, investigating ovarian cancer, endometrial cancer, and germ ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Germ Cell Tumor
• Ovarian Cancer
• Ovarian Germ Cell Tumor
• Testicular Germ Cell Tumor

Drugs mentioned

• XmAb541

Snippet

Sponsor: Xencor, Inc. | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 1 | Status: RECRUITING